Table 1. Multivariate analysis for DFS and OS in patients with gliomas.
| Factors | DFS | OS | ||
|---|---|---|---|---|
| HR(95%CI) | P | HR(95%CI) | P | |
| Gender | 1.238(0.748-2.050) | 0.407 | 1.324(0.822-2.134) | 0.249 |
| Age | 1.000(0.982-1.019) | 0.994 | 0.990(0.973-1.007) | 0.254 |
| Predominant side | 0.769(0.499-1.186) | 0.234 | 0.618(0.411-0.931) | 0.021 |
| Predominant location | 0.830(0.580-1.187) | 0.307 | 0.922(0.666-1.275) | 0.623 |
| KPS | 0.969(0.936-1.002) | 0.068 | 0.982(0.952-1.013) | 0.253 |
| IDH status | 0.000(0.000-0.007) | 0.001 | 0.000(0.000-0.021) | 0.001 |
| miR-320a LI | 0.635(0.536-0.751) | <0.0001 | 0.707(0.616-0.811) | <0.0001 |
| SND1 LI | 1.655(1.219-2.247) | 0.001 | 1.697(1.202-2.395) | 0.003 |
| β-catenin LI | 1.326(0.928-1.894) | 0.122 | 1.015(0.730-1.412) | 0.928 |
| Ki-67 LI | 2.924(1.267-6.744) | 0.012 | 2.428(1.195-4.932) | 0.014 |
Abbreviations: HR, hazard ratio; CI, confidence interval; KPS, Karnofsky performance score; LI, labeling index.